Login to Your Account

Matinas Biopharma Raises $15M for Omega-3 Therapeutic

By Catherine Shaffer
Staff Writer

Monday, August 12, 2013
Poised to file an investigational new drug application for its lipid drug MAT9001, Tarpon Springs, Fla.-based Matinas Biopharma Holdings Inc. raised $15 million in a private placement financing.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription